Compass Therapeutics Growth Metrics (2023-2025) | CMPX

Growth Metrics Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) -14.27%-13.15%-12.28%-10.50%-18.43%-25.01%55.05%
Assets (QoQ) -4.68%-5.10%-7.74%2.72%-3.43%-4.15%-5.87%-6.38%-11.22%98.17%
Capital Expenditures Growth (1y) 340.00%-84.09%
Capital Expenditures (QoQ) -9.09%-10.00%
Cash & Equivalents Growth (1y) 60.89%0.65%22.82%81.82%-4.29%20.72%25.18%
Cash & Equivalents (QoQ) -28.67%57.83%-20.37%79.47%-55.38%92.58%17.88%-5.53%-43.71%99.71%
Cash from Investing Activities Growth (1y) -196.02%1,071.96%70.20%143.43%382.70%-198.10%-427.92%
Cash from Investing Activities (QoQ) -115.62%2,656.07%-62.97%-164.92%258.16%347.60%-47.03%-24.61%-154.88%-1,396.16%
Cash from Operations Growth (1y) -13.57%-6.34%-86.61%25.84%4.90%-10.02%1.83%
Cash from Operations (QoQ) 17.30%41.44%-108.61%-12.42%22.57%-2.76%17.09%-44.16%10.42%8.31%
EBIT Growth (1y) -31.50%-12.81%-2.62%-7.67%-40.69%-40.02%-29.23%
EBIT (QoQ) -37.34%10.58%-29.07%17.04%-17.82%18.65%-35.42%-8.40%-17.25%24.92%
EBT Growth (1y) -37.64%-15.94%-22.83%-23.55%-54.19%-61.10%-29.23%
EBT (QoQ) -43.91%11.65%-34.63%19.59%-21.22%6.40%-35.42%-0.36%-26.65%24.92%
Enterprise Value Growth (1y) -59.60%-103.70%34.10%55.58%55.18%3,087.06%124.86%
Enterprise Value (QoQ) -2.08%-62.58%-46.89%107.60%-108.96%1,456.75%-38.38%107.07%72.55%2.13%
EPS (Basic) Growth (1y) -33.33%-11.11%0.00%-10.00%-50.00%-40.00%0.00%
EPS (Basic) (QoQ) -50.00%11.11%-25.00%20.00%-25.00%20.00%-37.50%-9.09%-16.67%42.86%
Free Cash Flow Growth (1y) -13.57%-6.22%-87.04%25.89%4.77%-10.02%2.15%
Free Cash Flow (QoQ) 17.21%41.41%-108.41%-12.34%22.57%-3.17%17.42%-44.36%10.54%8.25%
Net Cash Flow Growth (1y) 93.00%44.90%61.15%198.64%-339.53%-326.04%30.01%
Net Cash Flow (QoQ) 2.15%243.86%-155.60%91.06%-670.76%520.73%-65.97%-139.83%-647.10%228.39%
Net Income Growth (1y) -37.64%-15.94%-22.83%-23.55%-54.19%-61.10%-29.23%
Net Income (QoQ) -43.91%11.65%-34.63%19.59%-21.22%6.40%-35.42%-0.36%-26.65%24.92%
Net Income towards Common Stockholders Growth (1y) -37.64%-15.94%-22.83%-23.55%-54.19%-61.10%-29.23%
Net Income towards Common Stockholders (QoQ) -43.91%11.65%-34.63%19.59%-21.22%6.40%-35.42%-0.36%-26.65%24.92%
Operating Income Growth (1y) -31.50%-12.81%-2.62%-7.67%-40.69%-40.02%-29.23%
Operating Income (QoQ) -37.34%10.58%-29.07%17.04%-17.82%18.65%-35.42%-8.40%-17.25%24.92%
Profit After Tax Growth (1y) -37.64%-15.94%-5.19%-12.06%-54.19%-52.04%-36.05%
Profit After Tax (QoQ) -43.91%11.65%-34.63%19.59%-21.22%19.85%-43.43%-10.64%-19.53%28.28%
Property, Plant & Equipment (Net) Growth (1y) -45.81%-50.83%-53.09%-60.69%-68.95%-77.87%-75.86%
Property, Plant & Equipment (Net) (QoQ) -12.31%-12.71%-14.56%-17.15%-20.43%-16.72%-28.40%-34.56%-43.29%-9.16%
Return on Assets Growth (1y) -10.00-14.00-24.00-8.00
Return on Assets (QoQ) -3.00-1.00-3.00-4.00-7.00-11.0013.00
Return on Capital Employed Growth (1y) -9.00-17.00-25.00-7.00
Return on Capital Employed (QoQ) -2.00-3.000.00-4.00-9.00-10.0017.00
Return on Equity Growth (1y) -12.00-20.00-34.00-11.00
Return on Equity (QoQ) -2.00-1.00-4.00-5.00-10.00-16.0019.00
Share-based Compensation Growth (1y) 58.09%30.28%35.26%39.87%25.51%31.59%-43.68%
Share-based Compensation (QoQ) 28.49%-0.18%-1.54%25.19%5.89%3.63%1.82%12.33%11.02%-55.64%
Shareholder's Equity Growth (1y) -10.39%-13.18%-13.53%-15.69%-29.79%-36.21%51.46%
Shareholder's Equity (QoQ) -3.98%-4.90%-7.19%5.74%-6.98%-5.27%-9.51%-11.94%-15.48%124.89%